Activation or tolerance of natural killer cells is modulated by ligand quality in a nonmonotonic manner

Biophysical Journal

Volumn 99, Issue 7, 2010, Pages 2028-2037

  Das, Jayajit ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS; VERTEBRATA;

EID: 77958488363     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.07.061     Document Type: Article

References (70)

1. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
2. Raulet, D. H. 2004. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5:996-1002.
3. Robbins, S. H., G. Bessou, M. Dalod. 2007. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 3:e123.
4. Kärre, K., H. G. Ljunggren, R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 319:675-678.
5. Fernandez, N. C., E. Treiner, D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 105:4416-4423.
6. Kim, S., J. Poursine-Laurent, W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 436:709-713.
7. MacDonald, H. R. 2005. NK cell tolerance: revisiting the central dogma. Nat. Immunol. 6:868-869.
8. Vivier, E., J. A. Nunès, and F. Veely. 2004. Natural killer cell signaling pathways. Science. 306:1517-1519.
9. Brodin, P., K. Kärre, and P. Hoglund. 2009. NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol. 30:143-149.
10. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9:495-502.
11. Raulet, D. H., W. Held, L. Corral. 1997. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155:41-52.
12. Moretta, A., C. Bottino, L. Moretta. 1990. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 172:1589-1598.
13. Raulet, D. H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3:781-790.
14. Hanke, T., H. Takizawa, D. H. Raulet. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity. 11:67-77.
15. Kampen, N. G. v. 1992. Stochastic Processes in Physics and Chemistry. North-Holland, Amsterdam, New York.
16. McAdams, H. H., and A. Arkin. 1997. Stochastic mechanisms in gene expression. Proc. Natl. Acad. Sci. USA. 94:814-819.
17. Jiang, K., B. Zhong, J. Y. Djeu. 2000. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1:419-425.
18. Takaki, R., S. R. Watson, and L. L. Lanier. 2006. DAP12: an adapter protein with dual functionality. Immunol. Rev. 214:118-129.
19. Poole, A. W., and M. L. Jones. 2005. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Cell. Signal. 17:1323-1332.
20. Veillette, A., S. Latour, and D. Davidson. 2002. Negative regulation of immunoreceptor signaling. Annu. Rev. Immunol. 20:669-707.
21. Chalifour, A., L. Scarpellino, W. Held. 2009. A role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education. Immunity. 30:337-347.
22. Yokoyama, W. M. 2008. Inhibitory receptors signal activation. Immunity. 29:515-517.
23. Fraser, I. D., and R. N. Germain. 2009. Navigating the network: signaling cross-talk in hematopoietic cells. Nat. Immunol. 10:327-331.
24. Ivashkiv, L. B. 2009. Cross-regulation ofsignaling by ITAM-associated receptors. Nat. Immunol. 10:340-347.
25. Hamerman, J. A., N. K. Tchao, L. L. Lanier. 2005. Enhanced Tolllike receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 6:579-586.
26. Riley, J. L. 2009. PD-1 signaling in primary T cells. Immunol. Rev. 229:114-125.
27. Barrow, A. D., and J. Trowsdale. 2006. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur. J. Immunol. 36:1646-1653.
28. Humphrey, M. B., L. L. Lanier, and M. C. Nakamura. 2005. Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol. Rev. 208:50-65.
29. Long, E. O. 2008. Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol. Rev. 224:70-84.
30. Biassoni, R., A. Pessino, A. Moretta. 1999. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity. Eur. J. Immunol. 29:1014-1020.
31. Mandelboim, O., and A. Porgador. 2001. NKp46. Int. J. Biochem. Cell Biol. 33:1147-1150.
32. McVicar, D. W., L. S. Taylor, L. H. Mason. 1998. DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J. Biol. Chem. 273:32934-32942.
33. Binstadt, B. A., K. M. Brumbaugh, and P. J. Leibson. 1997. Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:197-203.
34. Turnbull, I. R., and M. Colonna. 2007. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 7:155-161.
35. Daëron, M.,S. Jaeger, E. Vivier. 2008. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future. Immunol. Rev. 224:11-43.
36. Palacios, E. H., and A. Weiss. 2004. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene. 23:7990-8000.
37. Hesslein, D. G., R. Takaki, L. L. Lanier. 2006. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc. Natl. Acad. Sci. USA. 103:7012-7017.
38. Lowin-Kropf, B., B. Kunz, W. Held. 2002. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur. J. Immunol. 32:773-782.
39. Diefenbach, A., E. Tomasello, D. H. Raulet. 2002. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3:1142-1149.
40. Shoelson, S. E. 1997. SH2 and PTB domain interactions in tyrosine kinase signal transduction. Curr. Opin. Chem. Biol. 1:227-234.
41. Ottinger, E. A., M. C. Botfield, and S. E. Shoelson. 1998. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J. Biol. Chem. 273:729-735.
42. Pinheiro da Silva, F., M. Aloulou, R. C. Monteiro. 2008. Inhibitory ITAMs: a matter of life and death. Trends Immunol. 29:366-373.
43. Billadeau, D. D., K. M. Brumbaugh, P. J. Leibson. 1998. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188:549-559.
44. Crespo, P., K. E. Schuebel, X. R. Bustelo. 1997. Phosphotyrosine- dependent activation of Rac-1 GDP/GTP exchange by the vav proto- oncogene product. Nature. 385:169-172.
45. Altan-Bonnet, G., and R. N. Germain. 2005. Modeling T cell antigen discrimination based on feedback control of digital ERK responses. PLoS Biol. 3:e356.
46. Frank, C., C. Burkhardt, F.D. Böhmer. 2004. Effective dephosphor-ylation of Src substrates by SHP-1. J.Biol. Chem. 279:11375-11383.
47. Zhang, Z., K. Shen, P. A. Cole. 2003. The role of C-terminal tyro-sine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J. Biol. Chem. 278:4668-4674.
48. Stebbins, C. C., C. Watzl, E. O. Long. 2003. Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol. Cell. Biol. 23:6291-6299.
49. Stefanová, I., B. Hemmer, R. N. Germain. 2003. TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways. Nat. Immunol. 4:248-254.
50. McKeithan, T. W. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA. 92:5042-5046.
51. Goldstein, B., D. Coombs, W. S. Hlavacek. 2008. Kinetic proofreading model. Adv. Exp. Med. Biol. 640:82-94.
52. Zhao, Y., and Z. Y. Zhang. 2001. The mechanism of dephosphorylation of extracellular signal-regulated kinase 2 by mitogen-activated protein kinase phosphatase 3. J. Biol. Chem. 276:32382-32391.
53. Lis, M., M. N. Artyomov, A. K. Chakraborty. 2009. Efficient stochastic simulation of reaction-diffusion processes via direct compilation. Bioinformatics. 25:2289-2291.
54. Zilka, A., G. Landau, A. Porgador. 2005. Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46. Biochemistry. 44:14477-14485.
55. Natarajan, K., L. F. Boyd, D. H. Margulies. 1999. Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site. Immunity. 11:591-601.
56. Goldbeter, A., and D. E. Koshland, Jr. 1981. An amplified sensitivity arising from covalent modification in biological systems. Proc. Natl. Acad. Sci. USA. 78:6840-6844.
57. Artyomov, M. N., M. Mathur, A. K. Chakraborty. 2009. Stochastic bimodalities in deterministically monostable reversible chemical networks due to network topology reduction. J. Chem. Phys. 131:195103.
58. Samoilov, M., S. Plyasunov, and A. P. Arkin. 2005. Stochastic amplification and signaling in enzymatic futile cycles through noise-induced bistability with oscillations. Proc. Natl. Acad. Sci. USA. 102: 2310-2315.
59. Rajagopalan, S., and E. O. Long. 2005. Understanding how combinations of HLA and KIR genes influence disease. J. Exp. Med. 201:1025-1029.
60. Goldstein, B., J. R. Faeder, and W. S. Hlavacek. 2004. Mathematical and computational models of immune-receptor signalling. Nat. Rev. Immunol. 4:445-456.
61. Torigoe, C., J. K. Inman, and H. Metzger. 1998. An unusual mechanism for ligand antagonism. Science. 281:568-572.
62. Tai, L. H., M. L. Goulet, A. P. Makrigiannis. 2008. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J. Exp. Med. 205:3187-3199.
63. van Oers, N. S., B. Lowin-Kropf, A. Weiss. 1996. αβ T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity. 5:429-436.
64. Chiesa, S., M. Mingueneau, E. Tomasello. 2006. Multiplicity and plasticity of natural killer cell signaling pathways. Blood. 107:2364-2372.
65. Chu, D. H., C. T. Morita, and A. Weiss. 1998. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol. Rev. 165:167-180.
66. Brown, G. D. 2006. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 6:33-43.
67. Barber, D. F., M. Faure, and E. O. Long. 2004. LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173:3653-3659.
68. Bryceson, Y. T., M. E. March, E. O. Long. 2006. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 107:159-166.
69. Fassett, M. S., D. M. Davis, J. L. Strominger. 2001. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc. Natl. Acad. Sci. USA. 98:14547-14552.
70. Das, J., M. Kardar, and A. K. Chakraborty. 2009. Positive feedback regulation results in spatial clustering and fast spreading of active signaling molecules on a cell membrane. J. Chem. Phys. 130:245102.